Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 3;15(7):1870.
doi: 10.3390/pharmaceutics15071870.

Dose Optimization and Targeting Strategies of Anti-Infective Agents

Martin Šíma  1 , Ondřej Slanař  1
Affiliations
Editorial

Dose Optimization and Targeting Strategies of Anti-Infective Agents

Martin Šíma et al. Pharmaceutics. .

Abstract

Most drugs are currently developed, approved and marketed based on their effect on the majority of the population [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Huntjens D.W., Dijkstra J.A., Verwiel L.N., Slijkhuis M., Elbers P., Welkers M.R.A., Veldkamp A.I., Kuijvenhoven M.A., de Leeuw D.C., Abdullah-Koolmees H., et al. Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients. Pharmaceutics. 2023;15:163. doi: 10.3390/pharmaceutics15010163. - DOI - PMC - PubMed
    1. Katip W., Oberdorfer P., Kasatpibal N. Effectiveness and Nephrotoxicity of Loading Dose Colistin-Meropenem versus Loading Dose Colistin-Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection. Pharmaceutics. 2022;14:1266. doi: 10.3390/pharmaceutics14061266. - DOI - PMC - PubMed
    1. Sima M., Bobek D., Cihlarova P., Rysanek P., Rousarova J., Berousek J., Kuchar M., Vymazal T., Slanar O. Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Pharmaceutics. 2022;14:1627. doi: 10.3390/pharmaceutics14081627. - DOI - PMC - PubMed
    1. Zhang J., Wu M., Diao S., Zhu S., Song C., Yue J., Martins F.S., Zhu P., Lv Z., Zhu Y., et al. Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-beta-Lactamase and Serine-beta-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae. Pharmaceutics. 2023;15:251. doi: 10.3390/pharmaceutics15010251. - DOI - PMC - PubMed
    1. Hartinger J.M., Michalickova D., Dvorackova E., Hronova K., Krekels E.H.J., Szonowska B., Bednarova V., Benakova H., Kroneislova G., Zavora J., et al. Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications. Pharmaceutics. 2023;15:1394. doi: 10.3390/pharmaceutics15051394. - DOI - PMC - PubMed

Publication types

LinkOut - more resources